Price $70.45 |
Market Cap
6.64B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
24.9
|
P/B
2.38
|
P/S
2.56
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
80.4
|
Op. Cash Flow
380.6K
|
FCF
0.9
|
|
Op. Margin
17.00%
|
Net Margin
10.50%
|
ROE
10.10%
|
ROI
8.30%
|
|
ROA
5.60%
|
EPS Growth
42.10%
|
Current Ratio
1.3
|
Debt/Equity
48.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cytosorbents Corp (CTSO) | $3.22 | - | - | 136.1M | Strong Buy |
| Baudax Bio Inc (BXRX) | $1.62 | - | - | 4.8M | Strong Buy |
| Sesen Bio Inc (SESN) | $0.63 | - | - | 118.9M | Strong Buy |
| Shineco Inc (SISI) | $0.59 | - | - | 15.9M | Strong Buy |
| Dare Bioscience Inc (DARE) | $0.97 | - | - | 95M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
